Ameriprise Financial Inc. increased its stake in Halyard Health Inc. (NYSE:HYH) by 37.7% during the second quarter, Holdings Channel reports. The firm owned 161,795 shares of the company’s stock after buying an additional 44,268 shares during the period. Ameriprise Financial Inc. owned 0.35% of Halyard Health worth $5,260,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the company. LS Investment Advisors LLC increased its stake in shares of Halyard Health by 25.6% in the second quarter. LS Investment Advisors LLC now owns 3,241 shares of the company’s stock valued at $105,000 after buying an additional 661 shares during the period. Springbok Capital Management LLC increased its stake in shares of Halyard Health by 151.9% in the first quarter. Springbok Capital Management LLC now owns 6,800 shares of the company’s stock valued at $195,000 after buying an additional 4,100 shares during the period. Blair William & Co. IL bought a new stake in shares of Halyard Health during the second quarter valued at about $229,000. Bank of Montreal Can bought a new stake in shares of Halyard Health during the second quarter valued at about $268,000. Finally, Bank of Hawaii bought a new stake in shares of Halyard Health during the second quarter valued at about $272,000. Hedge funds and other institutional investors own 82.93% of the company’s stock.
Shares of Halyard Health Inc. (NYSE:HYH) traded down 0.15% on Friday, reaching $34.21. 18,283 shares of the company were exchanged. The firm has a 50 day moving average price of $34.99 and a 200-day moving average price of $32.81. The stock’s market capitalization is $1.60 billion. Halyard Health Inc. has a 12-month low of $22.76 and a 12-month high of $37.31.
Halyard Health (NYSE:HYH) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported $0.45 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.36 by $0.09. Halyard Health had a negative net margin of 27.63% and a positive return on equity of 8.91%. The business earned $400 million during the quarter, compared to the consensus estimate of $383.08 million. During the same period in the prior year, the firm posted $0.52 EPS. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, analysts predict that Halyard Health Inc. will post $1.82 EPS for the current fiscal year.
Several equities research analysts have issued reports on HYH shares. Deutsche Bank AG raised their price objective on shares of Halyard Health from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. Stifel Nicolaus raised their target price on shares of Halyard Health from $37.00 to $38.00 and gave the stock a “buy” rating in a report on Thursday, August 4th. TheStreet raised shares of Halyard Health from a “sell” rating to a “hold” rating in a report on Friday, July 8th. Finally, Zacks Investment Research cut shares of Halyard Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $36.00.
Halyard Health Company Profile
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health Inc. (NYSE:HYH).
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.